Valneva Aktie
3,62
EUR
+0,05
EUR
+1,40
%
3,32
EUR
+1,16
EUR
+53,75
%
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 139,58 GBP | +21,14% |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +30,83% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 2 | 1 | 9,68 EUR | +47,67% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +97,04% |
| MorphoSys | 0 | 1 | 0 | 68,00 EUR | - |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| QIAGEN N.V. | 4 | 3 | 0 | 45,00 EUR | +22,08% |
| Sanofi S.A. | 6 | 3 | 0 | 115,50 EUR | +10,80% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |